Operant Conditioning for Neuromodulation



Status:Recruiting
Conditions:Healthy Studies, Neurology
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:21 - 90
Updated:7/5/2018
Start Date:June 8, 2018
End Date:March 2020
Contact:Stacey L DeJong, PhD, PT
Email:stacey-dejong@uiowa.edu
Phone:319-335-6842

Use our guide to learn which trials are right for you!

Operant Conditioning of Spinal Reflexes and Motor Evoked Potentials

Emerging evidence demonstrates that animals and people can exert control over the level of
excitability in spinal and corticospinal neural circuits that contribute to movement. This
discovery has important implications, as it represents a new strategy to improve motor
control in people of all ability levels, including those with neurological conditions.
Operant conditioning is a well-studied mechanism of learning, in which the modification of a
behavior can be brought about by the consequence of the behavior, and reinforcement causes
behaviors to become more frequent. In recent years, operant conditioning has been applied to
spinally-mediated reflex responses in mice, rats, monkeys and people. By electrically
stimulating a peripheral nerve, recording the muscle response, and rewarding responses that
are within a desirable range, it is possible to increase or decrease the neural circuit's
excitability. This may alter the level of resting muscle tone and spasticity, as well the
muscle's contribution to planned movements and responses to unexpected events. Operant
conditioning of spinal reflexes has been applied to a lower limb muscle in healthy people and
those with spinal cord injuries. In this project, we will expand the use of operant
conditioning to muscles of the upper limb, demonstrating feasibility and efficacy in healthy
people and people post-stroke. We will determine whether operant conditioning can be used to
decrease excitability of spinal reflexes that activate a wrist flexor muscle. Additionally,
in a separate group of healthy people, we will determine whether operant conditioning can be
used in a similar way to increase corticospinal excitability. We will stimulate the motor
cortex with transcranial magnetic stimulation to elicit motor evoked potentials in the same
wrist flexor muscle, and will reward responses that exceed a threshold value. We will examine
the effects of these interventions on motor control at the wrist, using an innovative
custom-designed cursor-tracking task to quantify movement performance. We will determine
whether changes in spinal reflex excitability or corticospinal excitability alter motor
control. The overall goal of this research is to develop a new, evidence-based strategy for
rehabilitation that will improve recovery of upper limb function in people after stroke.


Inclusion Criteria for Healthy Group:

- Able and willing to provide informed consent

- Normal function of both upper extremities

- Generally in good health

Exclusion Criteria for Healthy Group:

- Any self-reported disease or disorder that might affect this study, including
neurologic, psychiatric, muscular, orthopedic, cardiac, vascular, pulmonary,
hematologic, infectious, immune, gastrointestinal, urogenital, integumentary,
oncologic, or endocrine conditions

- Any self-reported or demonstrated loss of sensation, passive range of motion, or motor
function affecting any part of the upper limb on either side

Inclusion Criteria for Stroke Group:

- Able and willing to provide informed consent

- Subcortical ischemic stroke OR incomplete spinal cord injury, diagnosed by a
neurologist at least 3 months before enrollment

- Upper limb sensorimotor impairment on one or both sides, as indicated by a score of 10
to 56 out of 66 points on the Fugl-Meyer Assessment of the Upper Extremity

- Cognitive ability that is normal or only mildly impaired, as indicated by a score of 9
or less on the Short Blessed Test

- Normal receptive and expressive language abilities, as indicated by a score of 0 on
the Best Language item of the National Institutes of Health Stroke Scale

Exclusion Criteria for Stroke Group:

- Any self-reported or medically documented disease or disorder that might affect this
study, including other neurologic conditions besides stroke or spinal cord injury,
psychiatric, muscular, orthopedic, cardiac, vascular, pulmonary, hematologic,
infectious, immune, gastrointestinal, urogenital, integumentary, oncologic, or
endocrine conditions

- Diagnosis of hemorrhagic stroke or hemorrhagic conversion

- Diagnosis of an infarct affecting the motor cortex
We found this trial at
1
site
101 Jessup Hall
Iowa City, Iowa 52242
(319) 335-3500
Principal Investigator: Stacey L DeJong, PhD, PT
Phone: 319-335-6842
University of Iowa With just over 30,000 students, the University of Iowa is one of...
?
mi
from
Iowa City, IA
Click here to add this to my saved trials